| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 05/11/2006 | WO2006048473A1 β-LACTAMIC RGD CYCLOPEPTIDES CONTAINING GAMMA (Ϝ) TURNS |
| 05/11/2006 | WO2006048139A1 Acylated nonadepsipeptides used as lysobactin derivatives |
| 05/11/2006 | WO2006047900A2 Novel topical application agents against mimic and age-related wrinkles |
| 05/11/2006 | US20060100160 Amino acid derived prodrugs of propofol, compositions and uses thereof |
| 05/11/2006 | US20060100158 For therapy and prophylaxis of Alzheimer's disease, diffuse Lewy body type of Alzheimer's disease, Down's syndrome, MCI ("Mild Cognitive Impairment"), Heriditary Cerebral Hemorrhage with Amyloidosis of Dutch-Type, Cerebral Amyloid Angiopathy, Traumatic Brain Injury, Stroke, Dementia, Parkinson's Disease |
| 05/11/2006 | CA2586704A1 Acylated nonadepsipeptides used as lysobactin derivatives |
| 05/11/2006 | CA2585621A1 Improved quenching methods for red blood cell inactivation process |
| 05/10/2006 | EP1654283A1 Improved method of purifying tfpi and tfpi analogs |
| 05/10/2006 | EP1654261A1 Hepatitis c inhibitor compounds |
| 05/10/2006 | EP1653988A2 Leukocyte internalized peptide-drug conjugates |
| 05/10/2006 | EP1653986A2 Treatment of cancers expressing p95 erbb2 |
| 05/10/2006 | EP1478383A4 Compositions and methods for promoting myocardial and peripheral angiogenesis |
| 05/10/2006 | EP1290012B1 2-amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentanoic acid amide derivatives |
| 05/10/2006 | EP1254159B1 Process for the preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridylalaninamides |
| 05/10/2006 | EP1210355B1 Glycoconjugates, glycoamino, acids, intermediates thereto, and uses thereof |
| 05/10/2006 | EP0684843B1 TECHNETIUM-99m LABELED PEPTIDES FOR DIAGNOSTIC IMAGING OF INFLAMMATION |
| 05/10/2006 | CN1771257A Process for the preparation of macrocyclic compounds by ruthenium complex catalysed metathesis reaction |
| 05/10/2006 | CN1771057A Releasable polymeric conjugates based on biodegradable linkers |
| 05/10/2006 | CN1771050A Macrocyclic hepatitis c serine protease inhibitors |
| 05/10/2006 | CN1769274A Pyrazinone protease inhibitors |
| 05/10/2006 | CN1255426C Peptides for treatment of erectile dysfunction |
| 05/10/2006 | CN1255422C Nucleosides |
| 05/10/2006 | CN1255392C Colchinol derivatives as angiogenesis inhibitors |
| 05/09/2006 | US7041789 RFRP-3 and DNA thereof |
| 05/09/2006 | US7041783 Survivin-binding proteins, encoding nucleic acids, and methods of use |
| 05/09/2006 | US7041698 Tripeptide analogs that inhibit the functioning of the NS3 protease encoded by Hepatitis C virus |
| 05/09/2006 | US7041639 Depsipeptide and congeners thereof for use as immunosuppressants |
| 05/09/2006 | US7041506 Fibronectins; fibroblast growth factors |
| 05/09/2006 | US7041314 GPE analogs and peptidominetics |
| 05/09/2006 | US7041297 Tumor antigen peptides originating in cyclophilin B |
| 05/09/2006 | CA2257328C Thiazole derivatives |
| 05/04/2006 | WO2006046977A1 Macrocyclic ghrelin receptor antagonists and methods of using the same |
| 05/04/2006 | WO2005048944A3 Activatable photodynamic therapy agents |
| 05/04/2006 | US20060094789 Alpha- and beta-amino acid hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors |
| 05/04/2006 | US20060094718 O-substituted hydroxyaryl derivatives |
| 05/04/2006 | US20060094665 Pharmaceutical angiostatic dipeptide compositions and methods of use thereof |
| 05/04/2006 | US20060094644 Capreomycin derivatives and their use as antibacterials |
| 05/04/2006 | US20060093585 Providing mammalian cell contacted with agent and adeno-associated virus (AAV), identifying agent that when contacted with mammalian cell enhances AAV transduction after viral binding to membrane of contacted mammalian cell and before second strand synthesis which yields expressible form of viral genome |
| 05/03/2006 | EP1242060B1 Treatment of metastatic disease |
| 05/03/2006 | EP0793500B1 Pharmaceutical compositions comprising nitric oxide-releasing polysaccharides |
| 05/03/2006 | CN1768079A Polypeptide |
| 05/03/2006 | CN1254482C Peptide preparing process |
| 05/03/2006 | CN1254276C Matrix metalloproteinase inhibitors as targeting components in diagnostic agents |
| 05/03/2006 | CN1254271C Hybrid polypeptides with enhanced pharmacokinetic properties |
| 05/02/2006 | USRE39088 Amide compounds and use of the same |
| 05/02/2006 | US7038084 Viricides; Aids therapy |
| 05/02/2006 | US7038077 2-Amino-bicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives; nervous system, psychological, and psychiatric disorders |
| 05/02/2006 | US7038010 Agents and methods for promoting bone growth |
| 05/02/2006 | US7037941 Alpha-and Beta-amino acid hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors |
| 05/02/2006 | US7037897 TRI-, TETRA-, and penta-peptides having antiangiogenic activity |
| 05/02/2006 | US7037890 For cancer therapy |
| 05/02/2006 | US7037673 Dipeptide production method, L-amino acid amide hydrolase used therein, and production method of L-amino acid amide hydrolase |
| 05/02/2006 | US7037670 Peptide substrates for assay of extracellular signal-regulated protein kinase 1 and 2 activity |
| 05/02/2006 | US7037502 Peptide for use in the treatment of inflammation |
| 04/27/2006 | WO2006045066A2 Labeled compounds for proteasome inhibition |
| 04/27/2006 | WO2006042478A1 Small-molecule inhibitors of coronaviral main protease, their preparation and use |
| 04/27/2006 | WO2006023396A3 Vla-4 antagonists |
| 04/27/2006 | US20060090223 Vectors to express desired amino acid sequence in cells; regeneration; endosperm tissues; rice, corn, wheat, barley |
| 04/27/2006 | US20060089346 Optionally fused aryl-substituted azepanones, oxazepanone or thiazepanones substituted with a dipeptide group, e.g., N2-[(3,5-difluorophenyl)acetyl]-N1-[(2R,3R)-2-(2,5-difluorophenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl]-L-alaninamide; secretase inhibitors for treating Alzheimer's disease |
| 04/27/2006 | US20060089312 Protease inhibitors |
| 04/27/2006 | US20060089300 Macrocyclic peptides active against the hepatitis C virus |
| 04/27/2006 | US20060088889 screening the peptide library of chemically synthesized peptides, each of the peptides comprising an N-terminal or C-terminal amino acid associated with enzymatic or chemical cleavage of a polypeptide for biological activity; e.g. screening for Clostridium perfringens growth inhibitors or enhancers |
| 04/27/2006 | US20060088471 Compounds for enzyme inhibition |
| 04/27/2006 | CA2584515A1 Labeled compounds for proteasome inhibition |
| 04/26/2006 | EP1649039A2 Crystallization reagent matrices and related methods and kits |
| 04/26/2006 | EP1648924A2 Dipeptide transglutaminase inhibitors and methods of using the same |
| 04/26/2006 | EP1648923A1 Spatially-defined macrocycles incorporating peptide bond surrogates |
| 04/26/2006 | EP1648922A1 Spatially-defined macrocyclic compounds useful for drug discovery |
| 04/26/2006 | EP1648917A2 Agonist polypeptide of receptor for zot and zonulin |
| 04/26/2006 | EP1294689B1 Preparation method of a novel beta crystalline form of perindopril tert-butylamine salt |
| 04/26/2006 | CN1763081A Antibiotic dipeptide and its chemical modifier, its preparation method and uses |
| 04/26/2006 | CN1763080A Peptide benzamide compound and its preparation method |
| 04/26/2006 | CN1763028A Novel ascorbic acid compounds, methods of synthesis and application use thereof |
| 04/26/2006 | CN1763027A Novel ascorbic acid compounds, methods of synthesis and application use thereof |
| 04/26/2006 | CN1253442C Novel thiazine or pyrazine derivatives |
| 04/26/2006 | CN1253423C Process for production of aspartyl dipeptide ester derivative, novel intermediate therefor, and process for production thereof |
| 04/25/2006 | US7034111 17867, a novel human aminopeptidase |
| 04/25/2006 | US7034109 Intracellular delivery of biological effectors |
| 04/25/2006 | US7034050 Animal growth regulators |
| 04/25/2006 | US7034043 Cell adhesion inhibitors |
| 04/25/2006 | US7034004 Peptide for controlling appetite |
| 04/25/2006 | US7034002 Angiotensin converting enzyme inhibitor |
| 04/25/2006 | US7033597 Intracellular delivery of biological effectors |
| 04/20/2006 | WO2006040374A1 Synthetic peptides which reduce or eliminate bags formed under the lower rim of the eyes and use thereof in cosmetic or dermopharmaceutical compositions |
| 04/20/2006 | US20060084613 Dipeptide enzyme inhibitor; antiinflammatory agents; autoimmune disease; wound healing agents |
| 04/20/2006 | US20060084610 Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments |
| 04/20/2006 | US20060084596 Administering a biodrug comprising a growth factor binding compounds having a central non-peptide organic scaffold, such as a calix[4]arene, to which arelinked cyclic tetrapeptides; angiogenesis inhibiters; antitumor agents; solid tumors;anticarciogenic agents; restenosis |
| 04/20/2006 | US20060084090 Modulation of interaction between Nod1 and Gram-negative bacteria by Nod1 response to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island (cagPAI) |
| 04/20/2006 | US20060083847 purified glycopeptide or peptide having the chemical structure containing valine-asparagine-histidine- threonine tetrapeptide bonded to a sugar such as xylose, mannose or fucose; strong effect of improving taste such as the function of imparting the kokumi taste to foods |
| 04/20/2006 | US20060083685 Opioid metallopeptide compositions and methods |
| 04/20/2006 | CA2583670A1 Synthetic peptides reducing or removing bags formed under the lower eye contour and their use in cosmetic or dermopharmaceutical compositions |
| 04/20/2006 | CA2582769A1 Solid phase peptide sythesis |
| 04/19/2006 | EP1646651A2 Novel peptidic conjugates for alopecia preventive and curative treatment |
| 04/19/2006 | EP1646631A1 Peptido-mimetic compounds containing rgd sequence useful as integrin inhibitors; and intermediates thereof |
| 04/19/2006 | EP1531846A4 Conjugates of ligand, linker and cytotoxic agent and related compositions and methods of use |
| 04/19/2006 | EP1481002B1 Histogranin-like peptides and non-peptides, processes for their preparation and uses thereof |
| 04/19/2006 | EP1476427A4 Peptide beta-strand mimics based on 1,2-dihydro-3(6h)-pyridinone |
| 04/19/2006 | EP1294395B1 A COMBINATION PRODUCT COMPRISING MELAGATRAN AND A FACTOR VIIa INHIBITOR |
| 04/19/2006 | EP1112284B1 Piperazine-4-phenyl derivatives as inhibitors of the interaction between mdm2 and p53 |
| 04/19/2006 | EP0873417B1 Compositions for the detection of proteases in biological samples and methods of use thereof |